TradingKey - CVS Health (CVS) reported earnings that beat market expectations for the eighth consecutive quarter, yet failed to win over investors. On November 4, the company announced plans to split its business into two independent publicly traded companies in the first half of 2028. Following the announcement, its stock plunged 12.5% to a near six-month low.

TradingKey - UnitedHealth heads into October 13 earnings with improving medical costs and Optum margins, but weaker Medicare Star Ratings and regulatory scrutiny add risk.

TradingKey - Medtronic (MDT) reported its first-quarter fiscal 2027 financial results, with both revenue and earnings exceeding market expectations, while raising its full-year growth outlook. Boosted by the strong earnings report, Medtronic shares rose nearly 9% in pre-market trading.

TradingKey - In August 2026, the upward momentum in US stocks broadened significantly. Moderna (MRNA) topped the S&P 500 constituents with a 156% gain, surging 375.9% year-to-date. Palantir (PLTR) followed closely behind, rising 51.5% in August, while enterprise software stocks as a whole extended their previous recovery.

TradingKey - Billionaire investor Bill Ackman's Pershing Square revealed in its latest disclosure that the firm initiated a new position in Netflix (NFLX) in the second quarter, while also buying Visa (V), Mastercard (MA), S&P Global (SPGI), Intercontinental Exchange (ICE), and Alcon (ALC), adding a total of six companies.

TradingKey - On July 28 ET, Berkshire Hathaway Class B shares (BRK.B) closed at $512.37, marking the highest closing price since November 28 of last year ($513.81), but remaining approximately 5% below the all-time closing high of $539.80 reached on May 2, 2025. Class A shares (BRK.A) also trended higher, closing at $768,010 on Tuesday, with an all-time high of $809,350 recorded on the same day.
